Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
NR3B
is a modulatory subunit of the NMDA receptor, abundantly expressed in both cranial and spinal somatic motoneurons and at lower levels in other regions of the brain as well. Recently, we found the human
NR3B
gene (GRIN3B) to be highly genetically heterogeneous, and that approximately 10% of the normal European-American population lacks
NR3B
due to homozygous occurrence of a null allele in the gene. Therefore, it is especially important to understand the phenotypic consequences of the genetic loss of
NR3B
in both humans and animal models. We here provide results of behavioral analysis of mice genetically lacking
NR3B
, which is an ideal animal model due to homogeneity in genetic and environmental background. The
NR3B
(-/-) mice are viable and fertile. Consistent with the expression of
NR3B
in somatic motoneurons, the
NR3B
(-/-) mice showed a moderate but significant impairment in motor learning or coordination, and decreased activity in their home cages. Remarkably, the
NR3B
(-/-) mice showed a highly increased social interaction with their familiar
cage
mates in their home
cage
but moderately increased anxiety-like behaviour and decreased social interaction in a novel environment, consistent with the inhibitory role of
NR3B
on the functions of NMDA receptors. This work is the first reporting of the functional significance of
NR3B
in vivo and may give insight into the contribution of genetic variability of
NR3B
in the phenotypic heterogeneity among human population.
...
PMID:Genetic ablation of NMDA receptor subunit NR3B in mouse reveals motoneuronal and nonmotoneuronal phenotypes. 1788 Mar 85